Header search > ticker > Open Stock TerminalSelect the market and trading date first when you need a specific listing or historical session.
TradingFloor AI · Stock TerminalRCKTW - Ticker AI Digest
Rocket Pharmaceuticals, Inc. Warrant 📰 1
0.00070000
| Today -30.00%
●
Important AI Risk Notice
Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.
Not investment advice.
Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate.
Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only.
Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally.
Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Rocket Pharmaceuticals, Inc. Warrant in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
RCKTW
Data 2026-08-28
Preview Mode
Core Deck
Deep Dive Modules
Digested News
Today's Catalysts (RCKTW) 1
RCKTW
15:16
Rocket Pharmaceuticals, Inc. Warrant
AI 0
Acquisitions 0
Admission 0
Agreement 0
Approvals 1
RCKTW
19:54
Rocket Pharmaceuticals, Inc. Warrant
Authorisation 0
Awards 0
BTC 0
BlockListing 0
Blockchain 0
Breakthrough 0
BuyBack 0
Cancellations 0
CashOffer 0
Circular 0
ClinicalTrial 0
Collaborate 0
ContractWin 0
Covid-19 0
Deals 0
Diamond 0
DirectorDealing 0
DirectorateChange 0
Discovery 0
Dividend 0
Exceeded 0
FCA 0
FDA 1
RCKTW
15:16
Rocket Pharmaceuticals, Inc. Warrant
Form83 0
GeneralMeeting 0
Grants 0
InvestmentPlan 0
IssueOfEquity 0
JV 0
Launch 0
Litigation 0
MonthlyFactsheet 0
NAV 0
NameChange 0
NewContract 0
Offers 0
Offtake 0
Orders 0
OwnShares 0
Partner 0
Patents 0
Placing 0
Positive 0
ProfitWarning 0
Proposals 0
Prospectus 0
Reports 0
Results 0
SchemeOfArrangement 0
Significant 0
Speculation 0
Strategic 0
Suspension 0
TR1 0
TVR 0
Takeover 0
US News 0
Understanding 0
Updates 0
Vaccine 0
Wins 0
Worth 0
All Market News (Last 30 Days) 3
RCKTW
15:16
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
19:54
Rocket Pharmaceuticals, Inc. Warrant
Today's AI
RCKTW · Agentic Market Intelligence
RCKTW intelligence is listening.
The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News
1 live catalyst is opening Today’s AI for RCKTW.
Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape
Data 2026-08-28
Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1
Today
Front Of Desk
Rocket Pharmaceuticals, Inc. Warrant has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
RCKTW signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.
This is the ticker-specific Today’s AI desk for Rocket Pharmaceuticals, Inc. Warrant. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.
Subscription Required
Bullish vs Bearish Scoring
AI + Financial Blend
Buy / Sell Trigger Engine
Today's AI Findings
Subscriber Unlock
Subscribe to unlock the full RCKTW Today’s AI cockpit.
Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.
- AI-scored market headlines with sentiment buckets and buzzword breakdowns.
- Forecast leaders ranked by projected gain against current market price.
- Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
- Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
- Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
- Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for RCKTW on 2026-08-28.
Fundamentals Matrix
About Rocket Pharmaceuticals, Inc. Warrant
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.
Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
0
Enterprise Value
0
Public Float
0
Broker Target
-
Shares Out
0
Long Interest
0
Short Interest
0
Exchange
NASDAQ
Currency Code
USD
ISIN
-
Ex-Dividend
-
Yield
0.00%
Dividend Rate
-
EPS
-
Market
NASDAQ
Standard Lists
Not currently ranked
Sector
-
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-
Financials Matrix
News And Alerts First
1 live alert now opens the financials desk for RCKTW.
Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts
Data 2026-08-28
Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1
Alerts
Front Of Desk
Rocket Pharmaceuticals, Inc. Warrant has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
-
Earnings Date
-
Net Debt
0
Cash
77.6M
EPS
-
Net Income
-223.1M
Revenue
0
Enterprise Value
0
Trailing PE
-
Forward PE
-
Price Sales TTM
-
Price Book MRQ
-
EV Revenue
-
EV EBITDA
-
Financial Forecastist
Mixed financial engine
Run the upgraded fundamentals refresh to populate annual and quarterly financial statement history here.
Net Income -22.4%
FCF -19.0%
Current Ratio 6.12x
Forward Rev 703.3K
Mixed
Quarter Revenue
0
-
vs prior comparable quarter
Net Margin
-
-
profitability pulse
Free Cash Flow
-45.5M
-19.0%
cash conversion
Net Debt / EBITDA
-
-
lower is cleaner
Revenue Engine
Latest quarter printed 0 with the top line stable against the last comparable period.
Profit Stack
Net income landed at -47.6M and the margin profile is stable. That usually tells us whether operating leverage is finally kicking in.
Balance-Sheet Pressure
Leverage history is not loaded yet.
Quarterly Revenue Runway
Actual revenue bars, consensus revenue where available, plus the terminal model path.
Profit And Cash Conversion
Net income and free cash flow moving together is usually what separates genuine improvement from noise.
Balance-Sheet Pressure
Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.
Annual Power Curve
Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
250.0K
Revenue Path
0.00
EPS / Earnings
Growth cue 0.0%
Q1 2026
Consensus
0
Revenue Path
-
EPS / Earnings
Growth cue 0.0%
Q2 2026
Consensus
16.5M
Revenue Path
-
EPS / Earnings
Growth cue 0.0%
Q3 2026
Consensus
703.3K
Revenue Path
-
EPS / Earnings
Growth cue 0.0%
FY 2026
Consensus
17.2M
Revenue Path
-
EPS / Earnings
Growth cue 0.0%
FY 2027
Consensus
19.8M
Revenue Path
-
EPS / Earnings
Growth cue +0.2%
Quarterly Statement Tape
Last 6 Quarters
| Period | Revenue | Net Income | FCF | Net Debt |
|---|---|---|---|---|
| Q1 2026 | 0 | -47.6M | -45.5M | - |
| Q4 2025 | 0 | -42.5M | -34.9M | - |
| Q3 2025 | 0 | -50.3M | -50.4M | - |
| Q2 2025 | 0 | -68.9M | -49.0M | - |
| Q1 2025 | 0 | -61.3M | -56.2M | - |
| Q4 2024 | 0 | -60.3M | -47.3M | - |
Annual Financial Power
Last 5 Years
| Period | Revenue | Net Income | EBITDA | FCF |
|---|---|---|---|---|
| FY 2025 | 0 | -223.1M | - | -190.5M |
| FY 2024 | 0 | -258.7M | - | -215.6M |
| FY 2023 | 0 | -245.6M | - | -211.4M |
| FY 2022 | 0 | -221.9M | -213.7M | -186.8M |
| FY 2021 | 0 | -169.1M | -163.2M | -128.9M |
Structure DNA
Market Structure DNA
Balanced Structure profile with trend mixed
0.0% of the register is locked by institutions and insiders, leaving 100.0% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.
Trend mixed
Balanced register
Moderate income rhythm
As Of 2026-07-07
Balanced Structure
Structure Score
40.2 / 100
Balanced Structure
Trend Stack
-
vs 50DMA / 200DMA
52W Position
-
auction position inside the yearly range
Ownership Lock
0.0%
0.0% institutions | 0.0% insiders
Pressure Pocket
100.0% free float
Vendor short-float fields were not supplied
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway
Trend inputs have not been populated enough yet to map the current runway.
Ownership Register
Institutions hold about 0.0% and insiders about 0.0%, locking roughly 0.0% of the register and leaving 100.0% in free float. That reads as balanced register.
Pressure Pocket
The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.
Capital Rhythm
Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.
Structure Score
One-glance gauge for the current market-structure regime.
Pillar Radar
Trend, ownership, pressure, and capital rhythm mapped on one wheel.
Position And Float Balance
Shows whether the stock is extended, tightly held, or carrying capital-return support.
Dividend Cadence Tape
Historical dividend-event counts help reveal how dependable the income rhythm has been.
Dividend Cadence Ledger
No cadence
| Year | Dividend Count | Context |
|---|---|---|
| Dividend history has not been normalized yet. | ||
Structure Facts
Live Snapshot
Implied Spot
-
derived from market cap / shares
52W High
0.08
upper auction edge
52W Low
0.00
lower auction edge
Beta
-
volatility character
Shares Out
0
fully diluted count
Shares Float
0
tradable register
Shares Short
16.5K
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
-
split date not supplied
Capital Radar
Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder
Short Data · RCKTW · Last 30 Days
Short D · 12/26 EMA spread with 9 signal
Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.
Short D waiting
Building RCKTW short-momentum read
Short D compares the ticker’s disclosed short-position momentum with its own signal line.
Short D—
Signal—
Momentum—
Declared Short Holders
Nexus Pulse Engine
Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending
Volatility Lab
ATR(14)
Realized Vol (20d)
Volume Spike Z
AI Charts
News And Alerts First
The alert tape opens the door for RCKTW, and AI Charts sits just below.
Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape
Data 2026-08-28
AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1
Today
Catalyst Pulse
Rocket Pharmaceuticals, Inc. Warrant has fresh news flow live now, so the tape is framing the chart workspace below.
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.
Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.
Automated Signalling
Automated AI Forecasts
Predictive MACD
Catalyst Beacons
Live Price Structure
AI AutoDetection
Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
RSI Gauge
Price Change
AI Forecast